Journal of Experimental Medicine, Vol 178, 1103-1107, Copyright © 1993 by Rockefeller University Press

ARTICLES

Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice

T Tanaka, F Kitamura, Y Nagasaka, K Kuida, H Suwa and M Miyasaka
Department of Immunology, Tokyo Metropolitan Institute of Medical Science, Japan.

The interleukin 2 receptor beta chain (IL-2R beta) is preferentially expressed in natural killer (NK) cells, but is not detected in a majority of resting T and B cells. We recently established a novel monoclonal antibody (mAb) to murine IL-2R beta and examined in vivo the effect of the mAb in mice. We found that intraperitoneal injection of the anti-IL-2R beta mAb into adult mice resulted in a selective in vivo elimination of splenic NK function in various mouse strains. The reduction of NK cell function is associated with complete disappearance of NK1.1+ cells in C57BL/6 mice. Other lymphocyte subsets in the thymus and spleen were uncompromised. T cell function was not affected by the mAb treatment as judged by allogeneic cytotoxic T cell induction. The single injection of anti-IL-2R beta mAb caused a long-term elimination of splenic NK cells, lasting for at least 5 wk. We also found that NK and/or NK precursor cells become susceptible to the mAb treatment only after birth, suggesting that functional maturation of NK cells in terms of IL-2R beta expression is a later event in the course of NK cell development. The use of the anti-IL-2R beta mAb will be useful in defining the physiological role of NK cells in host defense as well as dissecting their developmental pathway in vivo.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Taussig, D. C., Miraki-Moud, F., Anjos-Afonso, F., Pearce, D. J., Allen, K., Ridler, C., Lillington, D., Oakervee, H., Cavenagh, J., Agrawal, S. G., Lister, T. A., Gribben, J. G., Bonnet, D. (2008). Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 112: 568-575 [Abstract] [Full Text]  
• Simpson-Abelson, M. R., Sonnenberg, G. F., Takita, H., Yokota, S. J., Conway, T. F. Jr., Kelleher, R. J. Jr., Shultz, L. D., Barcos, M., Bankert, R. B. (2008). Long-Term Engraftment and Expansion of Tumor-Derived Memory T Cells Following the Implantation of Non-Disrupted Pieces of Human Lung Tumor into NOD-scid IL2R{gamma}null Mice. J. Immunol. 180: 7009-7018 [Abstract] [Full Text]  
• Ogino, H., Yano, S., Kakiuchi, S., Muguruma, H., Ikuta, K., Hanibuchi, M., Uehara, H., Tsuchida, K., Sugino, H., Sone, S. (2008). Follistatin Suppresses the Production of Experimental Multiple-Organ Metastasis by Small Cell Lung Cancer Cells in Natural Killer Cell-Depleted SCID Mice. Clin. Cancer Res. 14: 660-667 [Abstract] [Full Text]  
• Saitoh, O., Abiru, N., Nakahara, M., Nagayama, Y. (2007). CD8+CD122+ T Cells, a Newly Identified Regulatory T Subset, Negatively Regulate Graves' Hyperthyroidism in a Murine Model. Endocrinology 148: 6040-6046 [Abstract] [Full Text]  
• Li, S., Yan, Y., Lin, Y., Bullens, D. M., Rutgeerts, O., Goebels, J., Segers, C., Boon, L., Kasran, A., De Vos, R., Dewolf-Peeters, C., Waer, M., Billiau, A. D. (2007). Rapidly induced, T-cell independent xenoantibody production is mediated by marginal zone B cells and requires help from NK cells. Blood 110: 3926-3935 [Abstract] [Full Text]  
• Cittera, E., Leidi, M., Buracchi, C., Pasqualini, F., Sozzani, S., Vecchi, A., Waterfield, J. D., Introna, M., Golay, J. (2007). The CCL3 Family of Chemokines and Innate Immunity Cooperate In Vivo in the Eradication of an Established Lymphoma Xenograft by Rituximab. J. Immunol. 178: 6616-6623 [Abstract] [Full Text]  
• Kawai, T., Choi, U., Cardwell, L., DeRavin, S. S., Naumann, N., Whiting-Theobald, N. L., Linton, G. F., Moon, J., Murphy, P. M., Malech, H. L. (2007). WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4. Blood 109: 78-84 [Abstract] [Full Text]  
• Kobari, L., Giarratana, M. C., Gluckman, J. C., Douay, L., Rosenzwajg, M. (2006). Ex Vivo Expansion Does Not Alter the Capacity of Umbilical Cord Blood CD34+ Cells to Generate Functional T Lymphocytes and Dendritic Cells. Stem Cells 24: 2150-2157 [Abstract] [Full Text]  
• Bondanza, A., Valtolina, V., Magnani, Z., Ponzoni, M., Fleischhauer, K., Bonyhadi, M., Traversari, C., Sanvito, F., Toma, S., Radrizzani, M., La Seta-Catamancio, S., Ciceri, F., Bordignon, C., Bonini, C. (2006). Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood 107: 1828-1836 [Abstract] [Full Text]  
• Mikaelian, I., Hovick, M., Silva, K. A., Burzenski, L. M., Shultz, L. D., Ackert-Bicknell, C. L., Cox, G. A., Sundberg, J. P. (2006). Expression of Terminal Differentiation Proteins Defines Stages of Mouse Mammary Gland Development. Vet Pathol 43: 36-49 [Abstract] [Full Text]  
• Yano, S., Muguruma, H., Matsumori, Y., Goto, H., Nakataki, E., Edakuni, N., Tomimoto, H., Kakiuchi, S., Yamamoto, A., Uehara, H., Ryan, A., Sone, S. (2005). Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell-Depleted Severe Combined Immunodeficient Mice. Clin. Cancer Res. 11: 8789-8798 [Abstract] [Full Text]  
• Muguruma, H., Yano, S., Kakiuchi, S., Uehara, H., Kawatani, M., Osada, H., Sone, S. (2005). Reveromycin A Inhibits Osteolytic Bone Metastasis of Small-Cell Lung Cancer Cells, SBC-5, through an Antiosteoclastic Activity. Clin. Cancer Res. 11: 8822-8828 [Abstract] [Full Text]  
• Roychowdhury, S., Blaser, B. W., Freud, A. G., Katz, K., Bhatt, D., Ferketich, A. K., Bergdall, V., Kusewitt, D., Baiocchi, R. A., Caligiuri, M. A. (2005). IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease. Blood 106: 2433-2435 [Abstract] [Full Text]  
• Watanabe, M., Ohsugi, T., Shoda, M., Ishida, T., Aizawa, S., Maruyama-Nagai, M., Utsunomiya, A., Koga, S., Yamada, Y., Kamihira, S., Okayama, A., Kikuchi, H., Uozumi, K., Yamaguchi, K., Higashihara, M., Umezawa, K., Watanabe, T., Horie, R. (2005). Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-{kappa}B, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 106: 2462-2471 [Abstract] [Full Text]  
• Westerhuis, G., Maas, W. G. E., Willemze, R., Toes, R. E. M., Fibbe, W. E. (2005). Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance. Blood 106: 2215-2220 [Abstract] [Full Text]  
• Massa, C., Melani, C., Colombo, M. P. (2005). Chaperon and Adjuvant Activity of hsp70: Different Natural Killer Requirement for Cross-Priming of Chaperoned and Bystander Antigens. Cancer Res. 65: 7942-7949 [Abstract] [Full Text]  
• Voza, T., Vigario, A. M., Belnoue, E., Gruner, A. C., Deschemin, J.-C., Kayibanda, M., Delmas, F., Janse, C. J., Franke-Fayard, B., Waters, A. P., Landau, I., Snounou, G., Renia, L. (2005). Species-Specific Inhibition of Cerebral Malaria in Mice Coinfected with Plasmodium spp.. Infect. Immun. 73: 4777-4786 [Abstract] [Full Text]  
• Ohsugi, T., Horie, R., Kumasaka, T., Ishida, A., Ishida, T., Yamaguchi, K., Watanabe, T., Umezawa, K., Urano, T. (2005). In vivo antitumor activity of the NF-{kappa}B inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia. Carcinogenesis 26: 1382-1388 [Abstract] [Full Text]  
• Roychowdhury, S., Baiocchi, R. A., Vourganti, S., Bhatt, D., Blaser, B. W., Freud, A. G., Chou, J., Chen, C.-S., Xiao, J. J., Parthun, M., Chan, K. K., Eisenbeis, C. F., Ferketich, A. K., Grever, M. R., Chen, C.-S., Caligiuri, M. A. (2004). Selective Efficacy of Depsipeptide in a Xenograft Model of Epstein-Barr Virus-Positive Lymphoproliferative Disorder. JNCI J Natl Cancer Inst 96: 1447-1457 [Abstract] [Full Text]  
• Garbi, N., Arnold, B., Gordon, S., Hammerling, G. J., Ganss, R. (2004). CpG Motifs as Proinflammatory Factors Render Autochthonous Tumors Permissive for Infiltration and Destruction. J. Immunol. 172: 5861-5869 [Abstract] [Full Text]  
• Gao, J.-X., Liu, X., Wen, J., Caligiuri, M. A., Stroynowski, I., Zheng, P., Liu, Y. (2003). Two-signal requirement for activation and effector function of natural killer cell response to allogeneic tumor cells. Blood 102: 4456-4463 [Abstract] [Full Text]  
• Yano, S., Zhang, H., Hanibuchi, M., Miki, T., Goto, H., Uehara, H., Sone, S. (2003). Combined Therapy with a New Bisphosphonate, Minodronate (YM529), and Chemotherapy for Multiple Organ Metastases of Small Cell Lung Cancer Cells in Severe Combined Immunodeficient Mice. Clin. Cancer Res. 9: 5380-5385 [Abstract] [Full Text]  
• Yoshida, A., Tanaka, R., Murakami, T., Takahashi, Y., Koyanagi, Y., Nakamura, M., Ito, M., Yamamoto, N., Tanaka, Y. (2003). Induction of Protective Immune Responses against R5 Human Immunodeficiency Virus Type 1 (HIV-1) Infection in hu-PBL-SCID Mice by Intrasplenic Immunization with HIV-1-Pulsed Dendritic Cells: Possible Involvement of a Novel Factor of Human CD4+ T-Cell Origin. J. Virol. 77: 8719-8728 [Abstract] [Full Text]  
• Di Gaetano, N., Cittera, E., Nota, R., Vecchi, A., Grieco, V., Scanziani, E., Botto, M., Introna, M., Golay, J. (2003). Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo. J. Immunol. 171: 1581-1587 [Abstract] [Full Text]  
• Kakiuchi, S., Daigo, Y., Tsunoda, T., Yano, S., Sone, S., Nakamura, Y. (2003). Genome-Wide Analysis of Organ-Preferential Metastasis of Human Small Cell Lung Cancer in Mice. Mol Cancer Res 1: 485-499 [Abstract] [Full Text]  
• Ichiyama, K., Yokoyama-Kumakura, S., Tanaka, Y., Tanaka, R., Hirose, K., Bannai, K., Edamatsu, T., Yanaka, M., Niitani, Y., Miyano-Kurosaki, N., Takaku, H., Koyanagi, Y., Yamamoto, N. (2003). A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity. Proc. Natl. Acad. Sci. USA 100: 4185-4190 [Abstract] [Full Text]  
• Hill, H. C., Conway, T. F. Jr., Sabel, M. S., Jong, Y. S., Mathiowitz, E., Bankert, R. B., Egilmez, N. K. (2002). Cancer Immunotherapy with Interleukin 12 and Granulocyte-Macrophage Colony-stimulating Factor-encapsulated Microspheres: Coinduction of Innate and Adaptive Antitumor Immunity and Cure of Disseminated Disease. Cancer Res. 62: 7254-7263 [Abstract] [Full Text]  
• Sedger, L. M., Hou, S., Osvath, S. R., Glaccum, M. B., Peschon, J. J., van Rooijen, N., Hyland, L. (2002). Bone Marrow B Cell Apoptosis During In Vivo Influenza Virus Infection Requires TNF-{alpha} and Lymphotoxin-{alpha}. J. Immunol. 169: 6193-6201 [Abstract] [Full Text]  
• Egilmez, N. K., Hess, S. D., Chen, F.-A., Takita, H., Conway, T. F., Bankert, R. B. (2002). Human CD4+ Effector T Cells Mediate Indirect Interleukin-12- and Interferon-{gamma}-dependent Suppression of Autologous HLA-negative Lung Tumor Xenografts in Severe Combined Immunodeficient Mice. Cancer Res. 62: 2611-2617 [Abstract] [Full Text]  
• Kerre, T. C. C., De Smet, G., De Smedt, M., Zippelius, A., Pittet, M. J., Langerak, A. W., De Bosscher, J., Offner, F., Vandekerckhove, B., Plum, J. (2002). Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34+ cells. Blood 99: 1620-1626 [Abstract] [Full Text]  
• Cao, T., Meuleman, P., Desombere, I., Sallberg, M., Leroux-Roels, G. (2001). In Vivo Inhibition of Anti-Hepatitis B Virus Core Antigen (HBcAg) Immunoglobulin G Production by HBcAg-Specific CD4+ Th1-Type T-Cell Clones in a hu-PBL-NOD/SCID Mouse Model. J. Virol. 75: 11449-11456 [Abstract] [Full Text]  
• Kawarada, Y., Ganss, R., Garbi, N., Sacher, T., Arnold, B., Hammerling, G. J. (2001). NK- and CD8+ T Cell-Mediated Eradication of Established Tumors by Peritumoral Injection of CpG-Containing Oligodeoxynucleotides. J. Immunol. 167: 5247-5253 [Abstract] [Full Text]  
• Kerre, T. C. C., De Smet, G., De Smedt, M., Offner, F., De Bosscher, J., Plum, J., Vandekerckhove, B. (2001). Both CD34+38+ and CD34+38- Cells Home Specifically to the Bone Marrow of NOD/LtSZ scid/scid Mice but Show Different Kinetics in Expansion. J. Immunol. 167: 3692-3698 [Abstract] [Full Text]  
• Bai, X.-F., Gao, J.-X., Liu, J., Wen, J., Zheng, P., Liu, Y. (2001). On the Site and Mode of Antigen Presentation for the Initiation of Clonal Expansion of CD8 T Cells Specific for a Natural Tumor Antigen. Cancer Res. 61: 6860-6867 [Abstract] [Full Text]  
• Portis, T., Harding, J. C., Ratner, L. (2001). The contribution of NF-{kappa}B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors. Blood 98: 1200-1208 [Abstract] [Full Text]  
• Cao, T., Lazdina, U., Desombere, I., Vanlandschoot, P., Milich, D. R., Sallberg, M., Leroux-Roels, G. (2001). Hepatitis B Virus Core Antigen Binds and Activates Naive Human B Cells In Vivo: Studies with a Human PBL-NOD/SCID Mouse Model. J. Virol. 75: 6359-6366 [Abstract] [Full Text]  
• Hafner, M., Zawatzky, R., Hirtreiter, C., Buurman, W. A., Echtenacher, B., Hehlgans, T., Mannel, D. N. (2001). Antimetastatic Effect of CpG DNA Mediated by Type I IFN. Cancer Res. 61: 5523-5528 [Abstract] [Full Text]  
• Ikawa, T., Fujimoto, S., Kawamoto, H., Katsura, Y., Yokota, Y. (2001). Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc. Natl. Acad. Sci. USA 10.1073/pnas.091537598v1 [Abstract] [Full Text]  
• Depraetere, S., Verhoye, L., Leclercq, G., Leroux-Roels, G. (2001). Human B Cell Growth and Differentiation in the Spleen of Immunodeficient Mice. J. Immunol. 166: 2929-2936 [Abstract] [Full Text]  
• Sugano, M., Egilmez, N. K., Yokota, S. J., Chen, F.-A., Harding, J., Huang, S. K., Bankert, R. B. (2000). Antibody Targeting of Doxorubicin-loaded Liposomes Suppresses the Growth and Metastatic Spread of Established Human Lung Tumor Xenografts in Severe Combined Immunodeficient Mice. Cancer Res. 60: 6942-6949 [Abstract] [Full Text]  
• Nokihara, H., Yanagawa, H., Nishioka, Y., Yano, S., Mukaida, N., Matsushima, K., Sone, S. (2000). Natural Killer Cell-dependent Suppression of Systemic Spread of Human Lung Adenocarcinoma Cells by Monocyte Chemoattractant Protein-1 Gene Transfection in Severe Combined Immunodeficient Mice. Cancer Res. 60: 7002-7007 [Abstract] [Full Text]  
• Egilmez, N. K., Jong, Y. S., Sabel, M. S., Jacob, J. S., Mathiowitz, E., Bankert, R. B. (2000). In Situ Tumor Vaccination with Interleukin-12-encapsulated Biodegradable Microspheres: Induction of Tumor Regression and Potent Antitumor Immunity. Cancer Res. 60: 3832-3837 [Abstract] [Full Text]  
• Malek, T. R., Porter, B. O., Codias, E. K., Scibelli, P., Yu, A. (2000). Normal Lymphoid Homeostasis and Lack of Lethal Autoimmunity in Mice Containing Mature T Cells with Severely Impaired IL-2 Receptors. J. Immunol. 164: 2905-2914 [Abstract] [Full Text]  
• Nieswandt, B., Hafner, M., Echtenacher, B., Mannel, D. N. (1999). Lysis of Tumor Cells by Natural Killer Cells in Mice Is Impeded by Platelets. Cancer Res. 59: 1295-1300 [Abstract] [Full Text]  
• Oxenius, A., Karrer, U., Zinkernagel, R. M., Hengartner, H. (1999). IL-12 Is Not Required for Induction of Type 1 Cytokine Responses in Viral Infections. J. Immunol. 162: 965-973 [Abstract] [Full Text]  
• Hoshino, T., Winkler-Pickett, R. T., Mason, A. T., Ortaldo, J. R., Young, H. A. (1999). IL-13 Production by NK Cells: IL-13-Producing NK and T Cells Are Present In Vivo in the Absence of IFN-{gamma}. J. Immunol. 162: 51-59 [Abstract] [Full Text]  
• Hirose, K., Suzuki, H., Nishimura, H., Mitani, A., Washizu, J., Matsuguchi, T., Yoshikai, Y. (1998). Interleukin-15 May Be Responsible for Early Activation of Intestinal Intraepithelial Lymphocytes after Oral Infection with Listeria monocytogenes in Rats. Infect. Immun. 66: 5677-5683 [Abstract] [Full Text]  
• Wang, M., Ellison, C. A., Gartner, J. G., HayGlass, K. T. (1998). Natural Killer Cell Depletion Fails to Influence Initial CD4 T Cell Commitment In Vivo in Exogenous Antigen-Stimulated Cytokine and Antibody Responses. J. Immunol. 160: 1098-1105 [Abstract] [Full Text]  
• Carlyle, J. R., Michie, A. M., Cho, S. K., Zuniga-Pflucker, J. C. (1998). Natural Killer Cell Development and Function Precede {alpha}{beta} T Cell Differentiation in Mouse Fetal Thymic Ontogeny. J. Immunol. 160: 744-753 [Abstract] [Full Text]  
• Malissen, M., Pereira, P., Gerber, D. J., Malissen, B., DiSanto, J. P. (1997). The Common Cytokine Receptor gamma  Chain Controls Survival of gamma /delta T Cells. JEM 186: 1277-1285 [Abstract] [Full Text]  
• Suzuki, H., Duncan, G. S., Takimoto, H., Mak, T. W. (1997). Abnormal Development of Intestinal Intraepithelial Lymphocytes and Peripheral Natural Killer Cells in Mice Lacking the IL-2 Receptor beta  Chain. JEM 185: 499-506 [Abstract] [Full Text]  
• Binder, D., Fehr, J., Hengartner, H., Zinkernagel, R. M. (1997). Virus-induced Transient Bone Marrow Aplasia: Major Role of Interferon-alpha /beta during Acute Infection with the Noncytopathic Lymphocytic Choriomeningitis Virus. JEM 185: 517-530 [Abstract] [Full Text]  
• Ikawa, T., Fujimoto, S., Kawamoto, H., Katsura, Y., Yokota, Y. (2001). Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc. Natl. Acad. Sci. USA 98: 5164-5169 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS